Your trusted destination for CME, CPD & Medical Education across the Middle East.
The 12th Rheuma Assiut 2026 – Annual International Conference of Rheumatology and Rehabilitation Department is organized in collaboration with the Egyptian Society of Rheumatic Diseases. The congress brings together rheumatologists, physiatrists, rehabilitation specialists, and clinical researchers to explore modern management paradigms, innovative biologic therapies, and interdisciplinary rehabilitation strategies for autoimmune and rheumatic diseases.
The 12th Rheuma Assiut 2026 – Annual International Conference of Rheumatology and Rehabilitation Department stands as a flagship international medical congress dedicated to expanding scientific knowledge, clinical expertise, and diagnostic capabilities across rheumatology, clinical immunology, and physical rehabilitation. Hosted by the Rheumatology and Rehabilitation Department at Assiut University in academic partnership with the Egyptian Society of Rheumatic Diseases and Pure Spot Events Management, this milestone event takes place from December 2 to December 3, 2026, at Assiut University in Assiut, Egypt. The two-day conference serves as an essential regional and international platform, assembling leading academic professors, consultant rheumatologists, rehabilitation physicians, physical therapists, immunologists, and junior medical trainees to examine evolving global clinical guidelines, translational research breakthroughs, and practical treatment strategies. The comprehensive scientific curriculum offers an immersive educational experience delivered through plenary lectures, evidence-based symposia, expert debates, interactive clinical case consultations, and practical skill-building workshops. Primary clinical focus areas cover modern diagnostic and management paradigms across autoimmune and inflammatory systemic conditions, including rheumatoid arthritis, systemic lupus erythematosus (SLE), ankylosing spondylitis, psoriatic arthritis, systemic sclerosis, Sjögren's syndrome, and systemic vasculitis. Dedicated scientific sessions highlight targeted biologic therapies, targeted synthetic disease-modifying antirheumatic drugs (tsDMARDs), Janus kinase (JAK) inhibitors, and individualized treatment protocols designed to achieve early disease remission and prevent long-term structural joint damage. In addition to advanced pharmacological strategies, the conference places a major focus on comprehensive physical medicine and neuro-musculoskeletal rehabilitation. Sessions examine functional recovery protocols for chronic musculoskeletal pain, multi-modal rehabilitation strategies, osteoarthritis management, osteoporosis prevention and treatment, and the expanding role of point-of-care musculoskeletal ultrasound (MSKUS) for diagnostic evaluation and image-guided joint injections. By integrating cutting-edge clinical research with real-world medical practice, the 12th Rheuma Assiut 2026 conference promotes interdisciplinary dialogue, fosters collaborative research networks, and elevates the standard of patient care for individuals affected by rheumatic and musculoskeletal diseases throughout Egypt and the surrounding region.
Updates on the diagnosis and management of systemic autoimmune conditions.
Latest guidelines for treating rheumatoid arthritis and spondyloarthritis.
Evidence-based approaches to managing degenerative joint diseases.
Integrating physical therapy into the comprehensive care of rheumatic patients.
Best practices for rehabilitation following orthopedic and joint surgeries.
Exploring new devices and technologies to aid patient mobility and function.
The role of ultrasound in early detection and monitoring of joint inflammation.
Utilizing MRI for the early diagnosis of complex rheumatic conditions.
Reviewing the efficacy and safety of new biologic agents in rheumatology.
Comprehensive approaches to managing chronic pain in rheumatic diseases.
Secure your seat and earn full credit eligibility with encrypted checkout.
Secure payment processing & PCI-aligned flow